Physician profile
Christopher D'Silva
NPI 1285254722
$229.80
in general payments reported to CMS, 2019-2025
9 companies · $35.30 in 2025
The $35.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $112 · 2024: $82.83 · 2025: $35.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $53.76 | 2023-2024 | Vraylar |
| Novo Nordisk INC | $48.33 | 2023-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $28.19 | 2024-2025 | Breztri, Airsupra |
| Dexcom, INC. | $21.82 | 2025 | Dexcom G6 Transmitter |
| Shield Therapeutics INC | $17.57 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.58 | 2023 | Xifaxan |
| Exact Sciences Corporation | $15.65 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $14.72 | 2023 | Mounjaro |
| Mylan Specialty L.P. | $13.18 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher D'Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.